Not recruitingISRCTN93724387
Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD
Research studyAges 6–17Germany
Understand this study
Who could participate?
Listed age limits: 6 years to 17 years.
- Listed locations
- Germany
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Johannes Gutenberg University of Mainz (Germany)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Germany
- Age range
- From 6 Years to 17 Years
- Official registry ID
- ISRCTN93724387
- Official title
Show the full official title
Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Germany
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johannes Gutenberg University of Mainz (Germany), a university.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
